Avalon Globocare Corp
ALBT1.260USD
-0.020-1.56%
收盤 12/24, 13:00（美東）報價延遲15分鐘
5.16M總市值
虧損本益比TTM
關於 Avalon Globocare Corp 公司
Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
Avalon Globocare Corp簡介
公司代碼ALBT
公司名稱Avalon Globocare Corp
上市日期Feb 22, 2016
CEOJin (David)
員工數量5
證券類型Ordinary Share
年結日Feb 22
公司地址4400 Route 9
城市FREEHOLD
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編07728
電話17327804400
網址https://www.avalon-globocare.com/
公司代碼ALBT
上市日期Feb 22, 2016
CEOJin (David)
Avalon Globocare Corp公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Wenzhao (Daniel) Lu
Mr. Wenzhao (Daniel) Lu
Chairman of the Board of Directors
Chairman of the Board of Directors
238.93K
--
Dr. David Jin, M.D., Ph.D.
Dr. David Jin, M.D., Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
103.00K
--
Ms. Meng Li
Ms. Meng Li
Chief Operating Officer, Secretary
Chief Operating Officer, Secretary
34.33K
--
Mr. Steven Andrew Sanders, J.D.
Mr. Steven Andrew Sanders, J.D.
Independent Director
Independent Director
--
--
Ms. Lourdes Felix
Ms. Lourdes Felix
Independent Director
Independent Director
--
--
Ms. Luisa Ingargiola
Ms. Luisa Ingargiola
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Wilbert J. (Billy) Tauzin, II
Mr. Wilbert J. (Billy) Tauzin, II
Director
Director
--
--
Dr. The Hon. Tevi Troy, Ph.D.
Dr. The Hon. Tevi Troy, Ph.D.
Independent Director
Independent Director
--
--
Mr. William B. Stilley, III
Mr. William B. Stilley, III
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Wenzhao (Daniel) Lu
Mr. Wenzhao (Daniel) Lu
Chairman of the Board of Directors
Chairman of the Board of Directors
238.93K
--
Dr. David Jin, M.D., Ph.D.
Dr. David Jin, M.D., Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
103.00K
--
Ms. Meng Li
Ms. Meng Li
Chief Operating Officer, Secretary
Chief Operating Officer, Secretary
34.33K
--
Mr. Steven Andrew Sanders, J.D.
Mr. Steven Andrew Sanders, J.D.
Independent Director
Independent Director
--
--
Ms. Lourdes Felix
Ms. Lourdes Felix
Independent Director
Independent Director
--
--
Ms. Luisa Ingargiola
Ms. Luisa Ingargiola
Chief Financial Officer
Chief Financial Officer
--
--
收入明細
由於公司未披露，未能獲取相關數據
由於公司未披露，未能獲取相關數據
業務
地區
由於公司未披露，未能獲取相關數據
股東統計
更新時間: 11月20日 週四
更新時間: 11月20日 週四
持股股東
股東類型
持股股東
持股股東
佔比
Lu (Wenzhao)
5.62%
Jin (David)
2.42%
Li (Meng)
0.81%
The Vanguard Group, Inc.
0.60%
Geode Capital Management, L.L.C.
0.52%
其他
90.03%
持股股東
持股股東
佔比
Lu (Wenzhao)
5.62%
Jin (David)
2.42%
Li (Meng)
0.81%
The Vanguard Group, Inc.
0.60%
Geode Capital Management, L.L.C.
0.52%
其他
90.03%
股東類型
持股股東
佔比
Individual Investor
8.87%
Investment Advisor
0.60%
Investment Advisor/Hedge Fund
0.52%
Hedge Fund
0.01%
其他
90.00%
機構持股
更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
29
48.23K
1.25%
--
2025Q3
31
48.23K
1.39%
+17.57K
2025Q2
33
19.75K
2.15%
+2.84K
2025Q1
33
16.91K
2.05%
-16.99K
2024Q4
35
16.66K
2.06%
-67.00
2024Q3
33
16.73K
1.75%
-236.00
2024Q2
33
16.96K
1.41%
+10.31K
2024Q1
31
6.65K
1.69%
-5.84K
2023Q4
32
10.45K
1.58%
+1.42K
2023Q3
39
9.06K
1.97%
+456.00
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Lu (Wenzhao)
238.93K
6.23%
+9.00
+0.00%
Mar 31, 2025
Jin (David)
103.00K
2.69%
--
--
Mar 31, 2025
Li (Meng)
34.33K
0.9%
+1.00
+0.00%
Mar 31, 2025
The Vanguard Group, Inc.
1.58K
0.04%
--
--
Aug 31, 2025
Geode Capital Management, L.L.C.
9.34K
0.24%
--
--
Aug 31, 2025
Tauzin (Wilbert J II)
1.04K
0.03%
+1.04K
--
Mar 31, 2025
Tower Research Capital LLC
241.00
0.01%
+241.00
--
Jun 30, 2025
Citi Investment Research (US)
951.00
0.02%
+951.00
--
Jun 30, 2025
BofA Global Research (US)
113.00
0%
+7.00
+6.60%
Jun 30, 2025
UBS Financial Services, Inc.
4.20K
0.11%
+1.64K
+64.05%
Jun 30, 2025
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Jan 04, 2023
Merger
10→1
Jan 04, 2023
Merger
10→1
公告日期
類型
比率
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Jan 04, 2023
Merger
10→1
Jan 04, 2023
Merger
10→1
Jan 04, 2023
Merger
10→1
Jan 04, 2023
Merger
10→1
常見問題
Avalon Globocare Corp的前五大股東是誰？
Avalon Globocare Corp的前五大股東如下：
Lu (Wenzhao)持有股份：238.93K佔總股份比例：6.23%。
Jin (David)持有股份：103.00K佔總股份比例：2.69%。
Li (Meng)持有股份：34.33K佔總股份比例：0.90%。
The Vanguard Group, Inc.持有股份：1.58K佔總股份比例：0.04%。
Geode Capital Management, L.L.C.持有股份：9.34K佔總股份比例：0.24%。
Lu (Wenzhao)持有股份：238.93K佔總股份比例：6.23%。
Jin (David)持有股份：103.00K佔總股份比例：2.69%。
Li (Meng)持有股份：34.33K佔總股份比例：0.90%。
The Vanguard Group, Inc.持有股份：1.58K佔總股份比例：0.04%。
Geode Capital Management, L.L.C.持有股份：9.34K佔總股份比例：0.24%。
Avalon Globocare Corp的前三大股東類型是什麼？
Avalon Globocare Corp 的前三大股東類型分別是：
Lu (Wenzhao)
Jin (David)
Li (Meng)
Lu (Wenzhao)
Jin (David)
Li (Meng)
有多少機構持有Avalon Globocare Corp(ALBT)的股份？
截至2025Q4，共有29家機構持有Avalon Globocare Corp的股份，合計持有的股份價值約為48.23K，占公司總股份的1.25% 。與2025Q3相比，機構持股有所增加，增幅為-0.14%。
哪個業務部門對Avalon Globocare Corp的收入貢獻最大？
在--，--業務部門對Avalon Globocare Corp的收入貢獻最大，創收--，占總收入的--% 。
